Results 151 to 160 of about 25,211 (207)

Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa. [PDF]

open access: yesBr J Dermatol
Pathmarajah P   +24 more
europepmc   +1 more source

Inflammatory modulation by cord blood stem cells prevented digit deformation in recessive dystrophic epidermolysis bullosa. [PDF]

open access: yesMol Ther
Anderson-Crannage M   +12 more
europepmc   +1 more source

Results of a non-randomized, open-label phase I study evaluating the novel immunomodulatory peptide TCP-25 for treatment of dystrophic epidermolysis bullosa. [PDF]

open access: yesOrphanet J Rare Dis
Wallblom K   +8 more
europepmc   +1 more source

Human urine-derived stem cells rescue cutaneous manifestation and suppress inflammation and fibrosis <i>in vitro</i> and in a mouse model of recessive dystrophic epidermolysis bullosa. [PDF]

open access: yesBurns Trauma
Zhou X   +15 more
europepmc   +1 more source

Natural history study of recessive dystrophic epidermolysis bullosa wounds and patient reported outcomes using mobile application home photography. [PDF]

open access: yesSci Rep
Fulchand S   +9 more
europepmc   +1 more source

Systems immunology integrates the complex endotypes of recessive dystrophic epidermolysis bullosa. [PDF]

open access: yesNat Commun
Hirt N   +15 more
europepmc   +1 more source

Efficacy and Safety of the Topical Gene Therapy Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Study of Japanese Subjects With Dystrophic Epidermolysis Bullosa. [PDF]

open access: yesJ Dermatol
Natsuga K   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy